Device: luminor 14m & luminor 35
Number of patients: 215
Follow up: 12-month
Types of lesions: Stenotic or high occlusive lesions in femoropopliteal and below de knee arteries.
Luminor shows a freedom from target lesion revascularization higher than similar studies (89.60%), proving that luminor DCB is a reliable choice for the treatment of BTK lesions.
Dr. Vicente Riambau – Hospital Clínic (Barcelona, SPA)
Dr. Francisco Acín – Hospital Universitario de Getafe (Madrid, SPA)